Li Lu

699 total citations
24 papers, 557 citations indexed

About

Li Lu is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Li Lu has authored 24 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Biomedical Engineering and 4 papers in Oncology. Recurrent topics in Li Lu's work include Innovative Microfluidic and Catalytic Techniques Innovation (4 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Extracellular vesicles in disease (2 papers). Li Lu is often cited by papers focused on Innovative Microfluidic and Catalytic Techniques Innovation (4 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Extracellular vesicles in disease (2 papers). Li Lu collaborates with scholars based in China, United States and Singapore. Li Lu's co-authors include Paul R. Chiarot, Jeffrey W. Schertzer, Shenghui Wang, Xiao Li, He-Li Zhao, Guorong Xu, Jianmei Xu, Susanne Vikström, Olof Karlsson and Åke Wieslander and has published in prestigious journals such as Biochemistry, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Li Lu

22 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Lu China 11 250 246 131 74 66 24 557
Xiaodong Tong China 10 271 1.1× 246 1.0× 35 0.3× 37 0.5× 40 0.6× 12 547
Karine Gionnet France 5 151 0.6× 142 0.6× 49 0.4× 193 2.6× 55 0.8× 7 604
Wenjie Zhao China 13 160 0.6× 198 0.8× 21 0.2× 75 1.0× 67 1.0× 42 463
Yan Qin China 11 332 1.3× 169 0.7× 65 0.5× 167 2.3× 27 0.4× 17 672
Matthew Reynolds United Kingdom 15 138 0.6× 170 0.7× 16 0.1× 82 1.1× 46 0.7× 34 587
Tingjuan Gao China 15 154 0.6× 209 0.8× 21 0.2× 60 0.8× 42 0.6× 29 500
Paolo Canepa Italy 12 142 0.6× 175 0.7× 20 0.2× 74 1.0× 62 0.9× 42 414
Natalia Farkas United States 15 232 0.9× 146 0.6× 17 0.1× 148 2.0× 81 1.2× 33 670
Huiying Ding China 14 414 1.7× 100 0.4× 128 1.0× 275 3.7× 52 0.8× 20 690

Countries citing papers authored by Li Lu

Since Specialization
Citations

This map shows the geographic impact of Li Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Lu more than expected).

Fields of papers citing papers by Li Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Lu. The network helps show where Li Lu may publish in the future.

Co-authorship network of co-authors of Li Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Li Lu. A scholar is included among the top collaborators of Li Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Lu. Li Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Rui, Li Lu, Jia Liu, et al.. (2025). A platinum(iv)–crocetin nanoplatform with intracellular morphological transformation for enhanced colorectal cancer therapy. Journal of Materials Chemistry B. 13(22). 6483–6492.
2.
Xu, Wenli, et al.. (2025). Role of osteopontin in cancer: From pathogenesis to therapeutics (Review). Oncology Reports. 54(5). 1–13.
3.
Li, Min, Fan Zhang, Peng Huang, et al.. (2025). circSTIL mediates pirarubicin inhibiting the malignant phenotype of triple-negative breast cancer and acts as a biomarker in plasma exosomes. Molecular Immunology. 180. 86–95. 2 indexed citations
4.
Chen, Xinping, Chengwei Li, Yunxiang Liu, et al.. (2024). mPPTMP195 nanoparticles enhance fracture recovery through HDAC4 nuclear translocation inhibition. Journal of Nanobiotechnology. 22(1). 261–261. 1 indexed citations
5.
Ren, Guodong, Xuewei Wang, Yingyu Ma, et al.. (2024). TME-responsive nanoplatform for multimodal imaging-guided synergistic precision therapy of esophageal cancer via inhibiting HIF-1α signal pathway. Journal of Controlled Release. 376. 518–529. 1 indexed citations
6.
Munyemana, Jean Claude, Xiuxia Sun, Li Lu, et al.. (2024). Strategic enhancement of collagen detection using lanthanide-functionalized collagen targeted peptides. Talanta. 283. 127170–127170. 3 indexed citations
7.
Wang, Meiling, Xiaowan Li, Hong Chen, et al.. (2023). Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer’s Disease and Parkinson’s Disease. International Journal of Molecular Sciences. 24(13). 11054–11054. 15 indexed citations
8.
Hu, Lei, Yu Liu, Hongqiang Wang, et al.. (2023). The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target. Molecules. 28(3). 1103–1103. 5 indexed citations
10.
Ren, Guodong, Jinyao Li, Yingyu Ma, et al.. (2022). Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform. Biomedicine & Pharmacotherapy. 153. 113506–113506. 17 indexed citations
11.
Yin, Yao, Li Lu, Jiaxi Jiang, et al.. (2022). Reversible bonding for microfluidic devices with UV release tape. Microfluidics and Nanofluidics. 26(3). 10 indexed citations
12.
Ma, Sufang, Qiang Yu, Li Lu, et al.. (2021). Recent Progress in Fluorescent Probes for the Detection of Ferrous Ion. Chinese Journal of Organic Chemistry. 41(1). 229–229. 2 indexed citations
13.
Lu, Li, et al.. (2016). Developments and perspectives on the polyamide-based reverse osmosis desalination membranes. 36(6). 138. 2 indexed citations
14.
Lu, Li, et al.. (2016). Membrane mechanical properties of synthetic asymmetric phospholipid vesicles. Soft Matter. 12(36). 7521–7528. 58 indexed citations
15.
Lu, Li, Jeffrey W. Schertzer, & Paul R. Chiarot. (2015). Continuous microfluidic fabrication of synthetic asymmetric vesicles. Lab on a Chip. 15(17). 3591–3599. 52 indexed citations
16.
Xu, Guorong, Shenghui Wang, He-Li Zhao, et al.. (2015). Layer-by-layer (LBL) assembly technology as promising strategy for tailoring pressure-driven desalination membranes. Journal of Membrane Science. 493. 428–443. 151 indexed citations
17.
Xiao, Fei, Hong Qiu, Hengxiang Cui, et al.. (2014). MicroRNA-885-3p inhibits the growth of HT-29 colon cancer cell xenografts by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling. Oncogene. 34(15). 1968–1978. 54 indexed citations
18.
Lu, Li, et al.. (2014). Removal of excess interfacial material from surface-modified emulsions using a microfluidic device with triangular post geometry. Microfluidics and Nanofluidics. 18(5-6). 1233–1246. 10 indexed citations
19.
Luo, Shuizhong, et al.. (2012). Characterization of amyloid-β precursor protein intracellular domain-associated transcriptional complexes in SH-SY5Y neurocytes. Neuroscience Bulletin. 28(3). 259–270. 5 indexed citations
20.
Lu, Li, Hongwen Gao, Ling Chen, et al.. (2007). Binding of Sudan II and IV to lecithin liposomes and E. coli membranes: insights into the toxicity of hydrophobic azo dyes. BMC Structural Biology. 7(1). 16–16. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026